Financials
- Market Capitalization 2.16 B
- Employee 325
- Founded 2006
- CEO Pravin Dugel
- Website www.ocutx.com
- Headquarter Delaware, United States
- FIGI BBG001J1BZV0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1904 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 27.59 USD | -2.78% | -7.14% | +15.05% | -31.66% | 2.28 B USD | ||
| 1919 | ZLAB Zai Lab Limited - American Depositary Shares | 19.62 USD | -4.25% | +2.24% | +11.67% | -26.49% | 2.20 B USD | ||
| 1961 | ADMA ADMA Biologics Inc - Common Stock | 8.97 USD | -1.21% | -3.34% | +8.60% | -51.93% | 2.08 B USD | ||
| 1963 | MESO Mesoblast Limited - American Depositary Shares | 16.22 USD | +5.05% | +12.64% | +16.77% | +44.95% | 2.08 B USD |
Frequently asked questions about Ocular Therapeutix, Inc. - Common Stock
What is the Ocular Therapeutix, Inc. - Common Stock stock price today?
The current price of Ocular Therapeutix, Inc. - Common Stock (OCUL) is 9.88. Over the past 24 hours, the stock has changed by -3.14%. Follow the OCUL chart for real-time price dynamics.
What is the stock ticker of Ocular Therapeutix, Inc. - Common Stock?
Ocular Therapeutix, Inc. - Common Stock trades under the ticker OCUL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ocular Therapeutix, Inc. - Common Stock stock going up?
OCUL has changed by +0.82% over the last week, +10.51% over the last month, and -14.09% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ocular Therapeutix, Inc. - Common Stock net income for the last quarter?
Ocular Therapeutix, Inc. - Common Stock reported net income of -88.61 M for the last quarter. The previous quarter showed -64.65 M, which means net income changed by -37.06%.
How many employees does Ocular Therapeutix, Inc. - Common Stock have?
As of the latest available data, Ocular Therapeutix, Inc. - Common Stock has 325 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ocular Therapeutix, Inc. - Common Stock EBITDA?
Ocular Therapeutix, Inc. - Common Stock EBITDA is -92.06 M, and its EBITDA margin is -853.57%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ocular Therapeutix, Inc. - Common Stock stock?
You can buy Ocular Therapeutix, Inc. - Common Stock (OCUL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ocular Therapeutix, Inc. - Common Stock stock?
Investing in Ocular Therapeutix, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OCUL chart and related analysis on metatrader.com as part of your research.